Fresenius Medical Care AG
SWB:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG
SWB:FME
|
DE |
|
Wall Financial Corp
F:62Q
|
CA |
|
P
|
Ponce Financial Group Inc
F:73V0
|
US |
|
A
|
Andritz AG
XHAM:AZ2
|
AT |
|
S
|
Smartone Telecommunications Holdings Ltd
SWB:SMA
|
HK |
|
Eagle Materials Inc
NYSE:EXP
|
US |
|
M
|
Moody's Corp
DUS:DUT
|
US |
Wall St Price Targets
FME Price Targets Summary
Fresenius Medical Care AG
According to Wall Street analysts, the average 1-year price target for FME is 41.82 EUR with a low forecast of 22.44 EUR and a high forecast of 62.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FME's stock price target?
Price Target
41.82
EUR
According to Wall Street analysts, the average 1-year price target for FME is 41.82 EUR with a low forecast of 22.44 EUR and a high forecast of 62.04 EUR.
What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Fresenius Medical Care AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Fresenius Medical Care AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.
